187.35
BATS BZX Real-Time Price
As of 10:50am ET
 -3.98 / -2.08%
Today’s Change
112.00
Today|||52-Week Range
274.03
-9.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$12.0B

Company Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Contact Information

Galapagos NV
Industriepark Mechelen Noord
Mechelen Brussels Region 2800
P:(321) 534-2900
Investor Relations:
(781) 460-1784

Employees

Shareholders

Other institutional5.93%
Mutual fund holders5.80%
Individual stakeholders--

Top Executives

Onno van de StolpeChief Executive Officer & Executive Director
Bart FiliusChief Operating & Financial Officer
Piet WigerinckChief Scientific Officer
Walid Abi-SaabChief Medical Officer
Andre HoekemaChief Business Officer